Get the Stockscreener App
20.98
0.05%
0.01
After Hours:
21.49
0.51
+2.43%
Beta Bionics Inc Stock (BBNX) Latest News
Beta Bionics, Inc. (BBNX): Among Stocks With At Least $10 Million In Insider Spending Recently - Yahoo Finance
Beta Bionics to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 - GlobeNewswire
When Will Beta Bionics Reveal Its 2024 Financial Performance? Key Date Announced - StockTitan
Leerink Partnrs Comments on Beta Bionics FY2024 Earnings - Defense World
Beta Bionics, Inc. (NASDAQ:BBNX) Receives $20.00 Average PT from Brokerages - Defense World
Kestra Medical ups IPO target to $150M - BioWorld Online
Beta Bionics initiated with a Buy at Lake Street - MSN
BofA starts coverage on insulin device maker Beta Bionics with 'buy' rating - TradingView
Beta Bionics (NASDAQ:BBNX) Now Covered by Analysts at Leerink Partners - Defense World
Beta Bionics (NASDAQ:BBNX) Now Covered by Analysts at Stifel Nicolaus - Defense World
BofA initiates Beta Bionics stock with Buy, sets $25 target - Investing.com India
BofA initiates Beta Bionics stock with Buy, sets $25 target By Investing.com - Investing.com South Africa
This Smithfield Foods Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
Wall Street bullish on insulin device maker Beta Bionics after IPO - TradingView
Leerink Partners sets $28 target for Beta Bionics stock By Investing.com - Investing.com South Africa
Leerink Partners sets $28 target for Beta Bionics stock - Investing.com India
Piper Sandler Initiates Beta Bionics at Overweight With $26 Price Target -February 24, 2025 at 07:15 am EST - Marketscreener.com
Stifel Initiates Beta Bionics at Buy With $25 Price Target -February 24, 2025 at 07:15 am EST - Marketscreener.com
Leerink Partners Initiates Beta Bionics at Outperform With $28 Price Target -February 24, 2025 at 07:11 am EST - Marketscreener.com
Piper Sandler sets Beta Bionics stock at overweight with $26 target By Investing.com - Investing.com South Africa
Piper Sandler sets Beta Bionics stock at overweight with $26 target - Investing.com India
Buy Recommendation for Beta Bionics: Leveraging Untapped Market Opportunities and Innovative Product Differentiation - TipRanks
Stifel initiates coverage on Beta Bionics stock with Buy rating, $25 target - Investing.com Australia
LADENBURG THALM/SH SH Begins Coverage on Beta Bionics (NASDAQ:BBNX) - MarketBeat
Stifel initiates coverage on Beta Bionics stock with Buy rating, $25 target By Investing.com - Investing.com South Africa
Beta Bionics rated new Neutral at Baird on valuation - MSN
Robert W. Baird Initiates Coverage on Beta Bionics (NASDAQ:BBNX) - Defense World
Beta Bionics (NASDAQ:BBNX) Stock Rating Upgraded by Baird R W - Defense World
Beta Bionics (NASDAQ:BBNX) Coverage Initiated at LADENBURG THALM/SH SH - Defense World
Baird starts Beta Bionics stock with neutral, sets $20 target By Investing.com - Investing.com South Africa
This Palantir Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga
Beta Bionics stock rated new Neutral at Baird (BBNX:NASDAQ) - Seeking Alpha
Ladenburg starts Beta Bionics stock at Buy, sets $31 PT By Investing.com - Investing.com South Africa
Ladenburg starts Beta Bionics stock at Buy, sets $31 PT - Investing.com
Ladenburg Thalmann Initiates Beta Bionics at Buy With $31 Price Target -February 20, 2025 at 07:39 am EST - Marketscreener.com
Baird starts Beta Bionics stock with neutral, sets $20 target - Investing.com India
Beta Bionics joins IPO uptick, aims to raise $114.4m in Nasdaq listing - MSN
Beta Bionics (NASDAQ:BBNX) Hits New 1-Year LowShould You Sell? - MarketBeat
Beta Bionics (NASDAQ:BBNX) Trading Down 5.7%Here's Why - MarketBeat
Kestra files for $100M IPO - BioWorld Online
Beta Bionics (NASDAQ:BBNX) Sets New 12-Month Low – Time to Sell? - Defense World
Beta Bionics Debuts at Nearly $1B Value - Orange County Business Journal
Eventide Asset Management, LLC Acquires Significant Stake in Bet - GuruFocus.com
Artificial Pancreas Maker Beta Bionics Just Started Trading. Should You Buy BBNX Stock After Its IPO? - MSN
Major Shareholder Makes Bold Move with Huge Stock Purchase - TipRanks
1.02%
2.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):